Resistance and cross-resistance of the IgM immunocytoma in the LOU/M Wsl rat for cisplatin, carboplatin, and iproplatin

[1]  B. Teicher,et al.  Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). , 1987, Cancer research.

[2]  D. Lydall,et al.  Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA. , 1986, Cancer research.

[3]  L. Pearlman,et al.  Interaction of two second generation platinum antitumor drugs with mouse thymocytes. , 1986, Cancer research.

[4]  T. McMillan,et al.  Development of drug resistance in a murine mammary tumour. , 1985, British Journal of Cancer.

[5]  D. Barnes,et al.  A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells. , 1985, Cancer research.

[6]  P. Lohman,et al.  Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II). , 1985, Cancer research.

[7]  A. Horwich,et al.  Advanced seminoma: treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8). , 1985, British Journal of Cancer.

[8]  A. Howell,et al.  Activity of JM9 in advanced ovarian cancer: a phase I-II trial. , 1985, Cancer treatment reports.

[9]  P. Lohman,et al.  Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. , 1985, Biochemistry.

[10]  L. V. van Putten,et al.  Preclinical studies on toxicity, antitumour activity and pharmacokinetics of cisplatin and three recently developed derivatives. , 1984, European journal of cancer & clinical oncology.

[11]  P. Lohman,et al.  Induction and repair of DNA cross-links in chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity. , 1984, Cancer research.

[12]  S. Harland,et al.  Phase II study of JM8, a new platinum analog, in advanced ovarian carcinoma. , 1983, Cancer treatment reports.

[13]  J. Vos,et al.  Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat. , 1983, Cancer research.

[14]  S. Waxman,et al.  Inhibition of amino acid transport by cis-diamminedichloroplatinum(II) derivatives in L1210 murine leukemia cells. , 1983, Cancer research.

[15]  A. Eastman.  Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II). , 1983, Biochemistry.

[16]  B. Issell,et al.  New platinum complexes in clinical trials. , 1983, Cancer treatment reviews.

[17]  S. Crooke,et al.  Characterization of in vitro deoxyribonucleic acid breakage and cross-linking induced by bis-isopropylamine)-trans-dihydroxy-cis-dichloroplatinum(IV). , 1982, Biochemistry.

[18]  A. Eastman,et al.  The significance of DNA cross-linking to cis-diamminedichloroplatinum(II)-induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cells. , 1982, Chemico-biological interactions.

[19]  F. Friedlos,et al.  The frequency of interstrand cross-links in DNA following reaction of cis-diamminedichloroplatinum(II) with cells in culture or DNA in vitro: stability of DNA cross-links and their repair. , 1982, Chemico-biological interactions.

[20]  P. Edminson,et al.  Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothionein. , 1981, Toxicology and applied pharmacology.

[21]  S. Crooke,et al.  Antileukemia (L1210) activity and toxicity of cis-dichlorodiammineplatinum(II) analogs. , 1979, Cancer treatment reports.

[22]  J. Burchenal,et al.  Rationale for development of platinum analogs. , 1979, Cancer treatment reports.

[23]  Connors Ta,et al.  Structure-activity relationships of the antitumor platinum coordination complexes. , 1979, Cancer treatment reports.

[24]  K. Kohn,et al.  DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity. , 1979, Cancer research.

[25]  Michael G. K. Jones,et al.  Selection of potential second generation platinum compounds , 1978 .

[26]  J. Burchenal,et al.  Studies of cross-resistance, synergistic combinations and blocking of activity of platinum derivatives , 1978 .

[27]  J. Burchenal,et al.  Lack of cross-resistance between certain platinum coordination compounds in mouse leukemia. , 1977, Cancer research.

[28]  J. Roberts,et al.  Interactions between mammalian cell DNA and inorganic platinum compounds. I. DNA interstrand cross-linking and cytotoxic properties of platinum(II) compounds. , 1974, Biochemical pharmacology.

[29]  H. Bazin,et al.  Transplantable immunoglobulin‐secreting tumours in rats. I. General features of LOU/Ws1 strain rat immunocytomas and their monoclonal proteins , 1972, International journal of cancer.

[30]  J. Roberts,et al.  Evidence for cross linking of complementary strands of dna in cultured mammalian cells by platinum compounds and mustard gas , 1972 .

[31]  J. Roberts,et al.  Cross-linking of Complementary Strands of DNA in Mammalian Cells by Antitumour Platinum Compounds , 1972, Nature.

[32]  I. Smith,et al.  Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II , 2004, Cancer Chemotherapy and Pharmacology.

[33]  J. Yarnold,et al.  Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer. , 1985, Cancer treatment reports.

[34]  B. Salles,et al.  Is DNA the Real Target of Antitumor Platinum Compounds , 1984 .

[35]  A. Calvert,et al.  JMS, successor to cisplatin in advanced ovarian carcinoma? , 1983, Lancet.

[36]  W. Rose,et al.  Antitumor activity and toxicity of cisplatin analogs. , 1982, Cancer treatment reports.

[37]  J. J. Roberts,et al.  REPAIR OF cis -PLATINUM (II) DIAMMINE DICHLORIDE-INDUCED DNA DAMAGE AND CELL SENSITIVITY , 1980 .

[38]  W. Rose,et al.  ANTITUMOR ACTIVITY OF PLATINUM ANALOGS , 1980 .

[39]  K. Harrap,et al.  ANTITUMOR, TOXIC AND BIOCHEMICAL PROPERTIES OF CISPLATIN AND EIGHT OTHER PLATINUM COMPLEXES , 1980 .

[40]  A. Thomson,et al.  The mechanism of action of antitumor platinum compounds. , 1979, Progress in nucleic acid research and molecular biology.